Biodegradable LNG Implant (SIPPR)
Description: Biodegradable PLGA implant releasing levonorgestrel (LNG) for 12 months or longer.
Delivery Method: Subdermal
Duration Type: Long-acting
Duration: 12 months or more
Dose: 22mg or more
Active Pharmaceutical Ingredient (API):
Inactive material: PLGA/PLA
Multipurpose Preventive Technology (MPT): No
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Began discovery in: 2013
Active Development: Yes
- This project is in early stage proof of concept (POC). Preliminary investigations of formulation and process have been done. The in vivo release experiments are ongoing and data has been achieved to prove the feasibility of this project.